MX2015017536A - Alquilacion con un alquil sulfonato de fluoroalquilo. - Google Patents
Alquilacion con un alquil sulfonato de fluoroalquilo.Info
- Publication number
- MX2015017536A MX2015017536A MX2015017536A MX2015017536A MX2015017536A MX 2015017536 A MX2015017536 A MX 2015017536A MX 2015017536 A MX2015017536 A MX 2015017536A MX 2015017536 A MX2015017536 A MX 2015017536A MX 2015017536 A MX2015017536 A MX 2015017536A
- Authority
- MX
- Mexico
- Prior art keywords
- alkyl
- preparing
- sulfonate
- fluoroalkyi
- reactants
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D498/12—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains three hetero rings
- C07D498/18—Bridged systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
- A61K31/436—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a six-membered ring having oxygen as a ring hetero atom, e.g. rapamycin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C303/00—Preparation of esters or amides of sulfuric acids; Preparation of sulfonic acids or of their esters, halides, anhydrides or amides
- C07C303/26—Preparation of esters or amides of sulfuric acids; Preparation of sulfonic acids or of their esters, halides, anhydrides or amides of esters of sulfonic acids
- C07C303/28—Preparation of esters or amides of sulfuric acids; Preparation of sulfonic acids or of their esters, halides, anhydrides or amides of esters of sulfonic acids by reaction of hydroxy compounds with sulfonic acids or derivatives thereof
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F7/00—Compounds containing elements of Groups 4 or 14 of the Periodic Table
- C07F7/02—Silicon compounds
- C07F7/08—Compounds having one or more C—Si linkages
- C07F7/18—Compounds having one or more C—Si linkages as well as one or more C—O—Si linkages
- C07F7/1804—Compounds having Si-O-C linkages
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Immunology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Epidemiology (AREA)
- Transplantation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201361837224P | 2013-06-20 | 2013-06-20 | |
| PCT/IB2014/062375 WO2014203185A1 (en) | 2013-06-20 | 2014-06-18 | Alkylation with an alkyl fluoroalkyl sulfonate |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MX2015017536A true MX2015017536A (es) | 2016-04-26 |
Family
ID=51014598
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX2015017536A MX2015017536A (es) | 2013-06-20 | 2014-06-18 | Alquilacion con un alquil sulfonato de fluoroalquilo. |
Country Status (13)
| Country | Link |
|---|---|
| US (1) | US20160130280A1 (enExample) |
| EP (1) | EP3010926B1 (enExample) |
| JP (1) | JP6574173B2 (enExample) |
| KR (1) | KR20160021243A (enExample) |
| CN (2) | CN105324386B (enExample) |
| AU (1) | AU2014282831B2 (enExample) |
| BR (1) | BR112015029521A2 (enExample) |
| CA (1) | CA2911104A1 (enExample) |
| HK (1) | HK1219727A1 (enExample) |
| IL (1) | IL242413B (enExample) |
| MX (1) | MX2015017536A (enExample) |
| RU (1) | RU2691728C2 (enExample) |
| WO (1) | WO2014203185A1 (enExample) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN104592254B (zh) * | 2015-02-08 | 2016-07-13 | 福建省微生物研究所 | 依维莫司的合成方法 |
| CN104876944B (zh) * | 2015-05-13 | 2017-11-10 | 普济生物科技（台州）有限公司 | 一种依维莫司的制备方法 |
| EP3109250A1 (en) * | 2015-06-23 | 2016-12-28 | Synbias Pharma AG | Method for the synthesis of rapamycin derivatives |
| CN108047265A (zh) * | 2017-11-24 | 2018-05-18 | 成都海创药业有限公司 | 一种依维莫司中间体的制备纯化方法 |
| RU2716714C1 (ru) * | 2019-08-26 | 2020-03-16 | Закрытое Акционерное Общество "Биокад" | Новый способ получения эверолимуса |
| CZ308817B6 (cs) * | 2019-09-12 | 2021-06-09 | Ratiochem, s.r.o. | Způsob výroby Everolimu |
| JP2023028473A (ja) * | 2021-08-19 | 2023-03-03 | 日本マイクロバイオファーマ株式会社 | エベロリムスの製造方法 |
| CN116082363B (zh) * | 2023-02-16 | 2025-11-21 | 西安交通大学 | 一种雷帕霉素40-位羟基的烷基化合成方法 |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB9221220D0 (en) * | 1992-10-09 | 1992-11-25 | Sandoz Ag | Organic componds |
| DE69624921T2 (de) * | 1995-06-09 | 2003-09-11 | Novartis Ag, Basel | Rapamycinderivate |
| CN1235608A (zh) * | 1996-09-09 | 1999-11-17 | 美国家用产品公司 | 烷基化的雷帕霉素衍生物 |
| JP4716280B2 (ja) * | 2004-03-01 | 2011-07-06 | テルモ株式会社 | Ｏ−アルキル化ラパマイシン誘導体の製造法 |
| EP1571151B1 (en) | 2004-03-01 | 2008-12-24 | Terumo Kabushiki Kaisha | Process for production of O-alkylated rapamycin derivatives |
| ES2296516B1 (es) | 2006-04-27 | 2009-04-01 | Laboratorios Almirall S.A. | Derivados de 4-(2-amino-1-hidroxietil)fenol como agonistas del receptor beta2 adrenergico. |
| TW200948361A (en) * | 2008-05-26 | 2009-12-01 | Chunghwa Chemical Synthesis & Biotech Co Ltd | Method for synthesizing Biolimus A9 and the like and method for improving stability of the same |
| CN102127092B (zh) * | 2010-01-18 | 2013-04-17 | 东南大学 | 依维莫斯的制备 |
| ES2753529T3 (es) * | 2010-11-19 | 2020-04-13 | Biocon Ltd | Procesos para la preparación de everolimús y productos intermedios del mismo |
| EP2670758B1 (en) * | 2011-02-04 | 2022-09-28 | Synthon BV | Process for making trisubstituted silyloxyethyl triflates |
-
2014
- 2014-06-18 JP JP2016520793A patent/JP6574173B2/ja not_active Expired - Fee Related
- 2014-06-18 US US14/895,523 patent/US20160130280A1/en not_active Abandoned
- 2014-06-18 BR BR112015029521A patent/BR112015029521A2/pt not_active IP Right Cessation
- 2014-06-18 WO PCT/IB2014/062375 patent/WO2014203185A1/en not_active Ceased
- 2014-06-18 AU AU2014282831A patent/AU2014282831B2/en not_active Ceased
- 2014-06-18 CN CN201480035390.4A patent/CN105324386B/zh not_active Expired - Fee Related
- 2014-06-18 RU RU2015156316A patent/RU2691728C2/ru active
- 2014-06-18 EP EP14732980.9A patent/EP3010926B1/en active Active
- 2014-06-18 CA CA2911104A patent/CA2911104A1/en not_active Abandoned
- 2014-06-18 HK HK16107634.9A patent/HK1219727A1/zh unknown
- 2014-06-18 KR KR1020167001145A patent/KR20160021243A/ko not_active Withdrawn
- 2014-06-18 CN CN201910054592.8A patent/CN109651396B/zh not_active Expired - Fee Related
- 2014-06-18 MX MX2015017536A patent/MX2015017536A/es unknown
-
2015
- 2015-11-02 IL IL242413A patent/IL242413B/en active IP Right Grant
Also Published As
| Publication number | Publication date |
|---|---|
| CN109651396A (zh) | 2019-04-19 |
| KR20160021243A (ko) | 2016-02-24 |
| CN105324386B (zh) | 2019-02-19 |
| WO2014203185A1 (en) | 2014-12-24 |
| CN109651396B (zh) | 2021-09-14 |
| IL242413B (en) | 2018-04-30 |
| HK1219727A1 (zh) | 2017-04-13 |
| EP3010926B1 (en) | 2019-11-20 |
| US20160130280A1 (en) | 2016-05-12 |
| BR112015029521A2 (pt) | 2017-07-25 |
| AU2014282831B2 (en) | 2016-12-01 |
| EP3010926A1 (en) | 2016-04-27 |
| CA2911104A1 (en) | 2014-12-24 |
| JP6574173B2 (ja) | 2019-09-11 |
| CN105324386A (zh) | 2016-02-10 |
| RU2015156316A (ru) | 2017-07-25 |
| RU2691728C2 (ru) | 2019-06-18 |
| AU2014282831A1 (en) | 2015-11-12 |
| JP2016523246A (ja) | 2016-08-08 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HK1219727A1 (zh) | 氟代烷基磺酸烷基酯的烷基化 | |
| MX350892B (es) | Síntesis de compuesto antiviral. | |
| MY198436A (en) | Triazole Silane Compound, Method for Synthesizing Said Compound and use Thereof | |
| NZ726356A (en) | Processes for preparing antiviral compounds | |
| MX2015002616A (es) | Sintesis de bis(fluorosulfonil)imida. | |
| PH12018501094A1 (en) | Process for the preparation of an apoptosis-inducing agent | |
| NZ715920A (en) | Pesticidal compositions and processes related thereto | |
| MY202331A (en) | Tetrazole silane compound, method for synthesizing said compound and use thereof | |
| PH12015501929A1 (en) | Substituted 2-azabicycles and their use as orexin receptor modulators | |
| AR102570A1 (es) | Síntesis de copanlisib, su sal diclorhidrato, intermediarios para su preparación e hidratos de los mismos | |
| SG195121A1 (en) | Process for the production of estetrol intermediates | |
| WO2014054058A3 (en) | Novel compounds, their synthesis and their uses | |
| EP4169924A3 (en) | Synthesis of halichondrins | |
| MX2017017022A (es) | Metodo para la sintesis de derivados de rapamicina. | |
| MX2017003238A (es) | Metodo para preparar 2'-o-fucosil-lactosa. | |
| NZ711192A (en) | Process for making benzoxazepin compounds | |
| EA201490998A1 (ru) | Способ получения сложных эфиров (5-фтор-2-метил-3-хинолин-2-илметил-индол-1-ил)-уксусной кислоты | |
| MX2012001067A (es) | Procesos para la alquilacion de pirazoles. | |
| MX2019000138A (es) | Procesos novedosos para preparacion de estimuladores de guanilato ciclasa soluble. | |
| SA518391413B1 (ar) | عملية تحضير وتبلر لليوزيمينول | |
| MX2013000294A (es) | Intermedios y procedimiento de preparación de un inhibidor específico de la trombina. | |
| MX389920B (es) | Procesos novedosos para preparar estimuladores de guanilato ciclasa soluble. | |
| TR201902673T4 (tr) | Medetomidin sentezinde yararlı olan 3-arilbütanlar gibi bileşiklerin hazırlanması için işlemler. | |
| IN2015DN02877A (enExample) | ||
| MX342390B (es) | Proceso para preparar 3-haloalquilpirazoles. |